Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barrios

Showing results (171-180 of 7,732) with videos related to

Pageof 774
Sort By:
Circulation|June 19, 2013
Letter from Barrios and Escobar regarding article, "trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the national health and nutrition examination survey, 2001 to 2010"Vivencio Barrios, Carlos Escobar
Medicina Clinica|June 8, 2013
[Atrial fibrillation in clinical practice: more answers are required]Vivencio Barrios, Carlos Escobar
Lancet (London, England)|June 11, 2013
Obesity, blood pressure, and cardiovascular outcomesVivencio Barrios, Carlos Escobar
Hypertension (Dallas, Tex. : 1979)|October 16, 2013
Hypertension and children: should we be aware?Vivencio Barrios, Carlos Escobar
The Journal of Emergency Medicine|November 9, 2013
Dabigatran and bleeding risk: the importance of a correct prescriptionCarlos Escobar, Vivencio Barrios
Semergen|March 9, 2016
[From clinical trials to clinical practice. Experience with rivaroxaban in the anticoagulant treatment of patients with non-valvular atrial fibrillation]V Barrios, C Escobar
Future Cardiology|April 29, 2016
Implications of edoxaban in the prevention and treatment of thromboembolic complications in clinical practiceVivencio Barrios, Carlos Escobar
Journal of Hypertension|June 3, 2016
Blood pressure goals revisitedVivencio Barrios, Carlos Escobar
International Journal of Clinical Practice|April 17, 2008
Calcium channel blocker-based combination therapy. The best approach in the treatment of high-risk hypertension?C Escobar, V Barrios
Revista Espanola De Cardiologia (English Ed.)|April 30, 2014
Does CHA₂DS₂-VASc score select patients who will benefit most from anticoagulation? ResponseVivencio Barrios, Carlos Escobar
Pageof 774

Showing results (171-180 of 7,732) with videos related to

Sort By:
Pageof 774
Circulation|June 19, 2013
Letter from Barrios and Escobar regarding article, "trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the national health and nutrition examination survey, 2001 to 2010"Vivencio Barrios, Carlos Escobar
Medicina Clinica|June 8, 2013
[Atrial fibrillation in clinical practice: more answers are required]Vivencio Barrios, Carlos Escobar
Lancet (London, England)|June 11, 2013
Obesity, blood pressure, and cardiovascular outcomesVivencio Barrios, Carlos Escobar
Hypertension (Dallas, Tex. : 1979)|October 16, 2013
Hypertension and children: should we be aware?Vivencio Barrios, Carlos Escobar
The Journal of Emergency Medicine|November 9, 2013
Dabigatran and bleeding risk: the importance of a correct prescriptionCarlos Escobar, Vivencio Barrios
Semergen|March 9, 2016
[From clinical trials to clinical practice. Experience with rivaroxaban in the anticoagulant treatment of patients with non-valvular atrial fibrillation]V Barrios, C Escobar
Future Cardiology|April 29, 2016
Implications of edoxaban in the prevention and treatment of thromboembolic complications in clinical practiceVivencio Barrios, Carlos Escobar
Journal of Hypertension|June 3, 2016
Blood pressure goals revisitedVivencio Barrios, Carlos Escobar
International Journal of Clinical Practice|April 17, 2008
Calcium channel blocker-based combination therapy. The best approach in the treatment of high-risk hypertension?C Escobar, V Barrios
Revista Espanola De Cardiologia (English Ed.)|April 30, 2014
Does CHA₂DS₂-VASc score select patients who will benefit most from anticoagulation? ResponseVivencio Barrios, Carlos Escobar
Pageof 774